Philips North America vs Suzhou Suncadia Biopharmaceuticals Co., Ltd.: FDA Enforcement Comparison

Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Suzhou Suncadia Biopharmaceuticals Co., Ltd..

Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.

Suzhou Suncadia Biopharmaceuticals Co., Ltd.: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.

Side by side

Philips North America — Warning letters0

Suzhou Suncadia Biopharmaceuticals Co., Ltd. — Warning letters0

Philips North America — Recalls355

Suzhou Suncadia Biopharmaceuticals Co., Ltd. — Recalls0

Philips North America — Approval records0

Suzhou Suncadia Biopharmaceuticals Co., Ltd. — Approval records0

Philips North America — Form 483s0

Suzhou Suncadia Biopharmaceuticals Co., Ltd. — Form 483s1

Timeline

Philips North America

Most recent FDA action: July 1, 2026

Full history →

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Most recent FDA action: January 6, 2025

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Philips North America vs Suzhou Suncadia Biopharmaceuticals Co., Ltd.: FDA Enforcement Comparison." Argus HQ, accessed August 27, 2026. https://argushq.ai/compare/philips-north-america-vs-suzhou-suncadia-biopharmaceuticals-co-ltd

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗